Gautam Patel Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

Gautam Patel is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 1.7 Million shares of AMRX, which is worth approximately $12.2 Million. The most recent transaction as insider was on Jun 10, 2025, when has been sold 56,426 shares (Class A Common Stock) at a price of $8.02 per share, resulting in proceeds of $452,536. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.7M

5.8% 3M change

16.83% 12M change

Total Value Held $12.2 Million

Gautam Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2025	SELL Open market or private sale	$452,536 $8.02 p/Share	56,426 Reduced 3.21%	1,704,050 Class A Common Stock
May 05 2025	SELL Open market or private sale	$39,200 $8.0 p/Share	4,900 Reduced 0.28%	1,720,218 Class A Common Stock
May 05 2025	BUY Exercise of conversion of derivative security	-	40,258 Added 2.24%	1,760,476 Class A Common Stock
May 02 2025	SELL Open market or private sale	$30,144 $8.0 p/Share	3,768 Reduced 0.22%	1,725,118 Class A Common Stock
Apr 01 2025	SELL Open market or private sale	$664,000 $8.3 p/Share	80,000 Reduced 4.42%	1,728,886 Class A Common Stock
Mar 03 2025	SELL Open market or private sale	$712,000 $8.9 p/Share	80,000 Reduced 4.24%	1,808,886 Class A Common Stock
Feb 03 2025	SELL Open market or private sale	$651,200 $8.14 p/Share	80,000 Reduced 4.06%	1,888,886 Class A Common Stock
Jan 08 2025	SELL Open market or private sale	$501,345 $8.01 p/Share	62,590 Reduced 3.08%	1,968,886 Class A Common Stock
Jan 02 2025	SELL Open market or private sale	$139,454 $8.01 p/Share	17,410 Reduced 0.85%	2,031,476 Class A Common Stock
May 10 2024	BUY Exercise of conversion of derivative security	-	76,453 Added 3.6%	2,048,886 Class A Common Stock
Jan 01 2024	SELL Other acquisition or disposition	-	33,458,067 Reduced 98.89%	374,318 Class A Common Stock
Jan 01 2024	BUY Bona fide gift	-	1,598,115 Added 44.76%	1,972,433 Class A Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	-	80,128 Added 17.63%	374,318 Class A Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	35,406 Added 10.74%	294,190 Class A Common Stock
Dec 17 2021	BUY Open market or private purchase	$210,500 $4.21 p/Share	50,000 Added 16.19%	258,784 Class A Common Stock
May 06 2021	BUY Exercise of conversion of derivative security	-	46,218 Added 18.12%	208,784 Class A Common Stock

Also insider at

SPB

Spectrum Brands Holdings, Inc. Consumer Defensive

Director

Gautam Patel

Director

Middleton, WI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX

Account